LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse

Toxicology and Applied Pharmacology

Volumn 211, Issue 1, 2006, Pages 53-63

  Islam, Zahidul ^a,b   Pestka, James J ^a,b,c  

^a Michigan State University ^*  (United States)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Deoxynivalenol; Immunotoxicology; Lipopolysaccharide; Mycotoxin; Thymus; Trichothecene; Vomitoxin

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DNA FRAGMENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TRICHOTHECENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VOMITOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LOSS; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; SENSITIZATION; THYMOCYTE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; ENDOTOXINS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IMMUNIZATION; INTERLEUKIN-1; INTERLEUKIN-6; IRIDOVIRIDAE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, MESSENGER; THYMUS GLAND; TRICHOTHECENES; TUMOR NECROSIS FACTOR-ALPHA; XENOBIOTICS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 31444448616     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.04.031     Document Type: Article

References (60)

1. S.S. Adler, S. Lowenbraun, B. Birch, R. Jarrell, and J. Garrard Anguidine: a broad phase II study of the Southeastern Cancer Study Group Cancer Treat. Rep. 68 1984 423 425
2. H.M. Ammann Is indoor mold contamination a threat to health? Part two J. Environ. Health 66 2003 47 49
3. R.J. Belt, C.D. Haas, U. Joseph, W. Goodwin, D. Moore, and B. Hoogstraten Phase I study of anguidine administered weekly Cancer Treat. Rep. 63 1979 1993 1995
4. L.M. Bigatello, S.A. Broitman, L. Fattori, M. Di Paoli, M. Pontello, G. Bevilacqua, and A. Nespoli Endotoxemia, encephalopathy, and mortality in cirrhotic patients Am. J. Gastroenterol. 82 1987 11 15
5. C. Bode, V. Kugler, and J.C. Bode Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess J. Hepatol. 4 1987 8 14
6. R. Bukowski, C. Vaughn, R. Bottomley, and T. Chen Phase II study of anguidine in gastrointestinal malignancies: a Southwest Oncology Group Study Cancer Treat. Rep. 66 1982 381 383
7. Y.J. Chung, H.R. Zhou, and J.J. Pestka Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol vomitoxin Toxicol. Appl. Pharmacol. 193 2003 188 201
8. L.J. Clifford, Q. Jia, and J.J. Pestka An improved method for the purification of the trichothecene deoxynivalenol vomitoxin from fusarium graminearum culture J. Agric. Food Chem. 51 2003 521 523
9. M.H. Cobb MAP kinase pathways Prog. Biophys. Mol. Biol. 71 1999 479 500
10. E.A. Deitch Microbial gastrointestinal translocation W.E. Fry Surgical Infections 1995 Little Brown and Co. Boston 707 715
11. P.A. DeSimone, F.A. Greco, and H.F. Lessner Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal Malignancies Cancer Treat. Rep. 63 1979 2015 2017
12. C. Dong, R.J. Davis, and R.A. Flavell MAP kinases in the immune response Annu. Rev. Immunol. 20 2002 55 72
13. L. Escoubet-Lozach, C.K. Glass, and S.I. Wasserman The role of transcription factors in allergic inflammation J. Allergy Clin. Immunol. 110 2002 553 564
14. R.A. Etzel Mycotoxins JAMA 287 2002 425 427
15. P.E. Ganey, and R.A. Roth Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents Toxicology 169 2001 195 208
16. P.E. Ganey, J.P. Luyendyk, J.F. Maddox, and R.A. Roth Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor Chem.-Biol. Interact. 150 2004 35 51
17. W. Goodwin, R. Stephens, J.D. McCracken, and C. Groppe Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treat. Rep. 65 1981 359
18. W.B. Henghold Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins Dermatol. Clin. 22 2004 257 262
19. M.S. Iordanov, D. Pribnow, J.L. Magun, T.H. Dinh, J.A. Pearson, S.L. Chen, and B.E. Magun Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28 S rRNA Mol. Cell. Biol. 17 1997 3373 3381
20. Z. Islam, and J.J. Pestka Role of IL-1β in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte apoptosis in mice Toxicol. Sci. 74 2003 93 102
21. Z. Islam, M. Nagase, T. Yoshizawa, K. Yamauchi, and N. Sakato T-2 toxin induces thymic apoptosis in vivo in mice Toxicol. Appl. Pharmacol. 148 1998 205 214
22. Z. Islam, Y.S. Moon, H.R. Zhou, L.E. King, P.J. Fraker, and J.J. Pestka Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids Toxicol. Appl. Pharmacol. 180 2002 43 55
23. Z. Islam, L.E. King, P.J. Fraker, and J.J. Pestka Differential induction of glucocorticoid-dependent apoptosis in murine lymphoid subpopulations in vivo following coexposure to lipopolysaccharide and vomitoxin deoxynivalenol Toxicol. Appl. Pharmacol. 187 2003 69 79
24. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu. Rev. Immunol. 20 2002 197 216
25. J.D. Laskin, D.E. Heck, and D.L. Laskin The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity Toxicol. Sci. 69 2002 289 291
26. J.Y. Lee, N.A. Kim, A. Sanford, and K.E. Sullivan Histone acetylation and chromatin conformation are regulated separately at the TNF-alpha promoter in monocytes and macrophages J. Leukocyte Biol. 73 2003 862 871
27. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
28. F. Miao, I.G. Gonzalo, L. Lanting, and R. Natarajan In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions J. Biol. Chem. 279 2004 18091 18097
29. Y. Moon, and J.J. Pestka Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases Toxicol. Sci. 69 2002 373 382
30. K.R. Palmer, B.I. Duerden, and C.D. Holdsworth Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery Gut 21 1980 851 854
31. J.J. Pestka, and A. Smolinski Deoxynivalenol: toxicology and potential effects on humans J. Toxicol. Environ. Health, Part B 8 2005 1 31
32. J.J. Pestka, D. Yan, and L.E. King Flow cytometric analysis of the effects of in vitro exposure to vomitoxin deoxynivalenol on apoptosis in murine T, B and IgA+ cells Food Chem. Toxicol. 32 1994 1125 1136
33. J.J. Pestka, H.R. Zhou, Y. Moon, and Y.J. Chung Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox Toxicol. Lett. 153 2004 61 73
34. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
35. I. Rahman Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases J. Biochem. Mol. Biol. 36 2003 95 109
36. S.G. Revankar Clinical implications of mycotoxins and Stachybotrys Am. J. Med. Sci. 325 2003 262 274
37. R.A. Roth, J.R. Harkema, J.P. Pestka, and P.E. Ganey Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? Toxicol. Appl. Pharmacol. 147 1997 300 311
38. A.M. Rutenburg, E. Sonnenblick, I. Koven, H.A. Aprahamian, L. Reiner, and J. Fine The role of intestinal bacteria in the development of dietary cirrhosis in rats Diet. Cirrhosis 1957 1 13
39. R. Rylander Endotoxin in the environment-Exposure and effects J. Endotoxin Res. 8 2002 241 252
40. J. Schletter, H. Heine, A.J. Ulmer, and E.T. Rietschel Molecular mechanisms of endotoxin activity Arch. Microbiol. 164 1995 383 389
41. V.I. Shifrin, and P. Anderson Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen activated protein kinase and induces apoptosis J. Biol. Chem. 274 1999 13922 13985
42. G. Spaeth, R.D. Specian, R.D. Berg, and E.A. Deitch Bulk prevents bacterial translocation induced by the oral administration of total parenteral nutrition solution JPEN, J. Parenter. Enteral Nutr. 14 1990 442 447
43. D.L. Sudakin Trichothecenes in the environment: relevance to human health Toxicol. Lett. 143 2003 97 107
44. K.E. Sullivan Regulation of inflammation Immunol. Res. 27 2003 529 538
45. J.H. Tai, and J.J. Pestka Synergistic interaction between the trichothecene T-2 toxin and Salmonella typhimurium lipopolysaccharide in C3H/HeN and C3H/HeJ mice Toxicol. Lett. 44 1988 191 200
46. J.H. Tai, and J.J. Pestka Impaired murine resistance to Salmonella typhimurium following oral exposure to the trichothecene T-2 toxin Food Chem.Toxicol. 26 1988 691 698
47. K. Tarao, K. So, T. Moroi, T. Ikeuchi, and T. Suyama Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance Gastroenterology 73 1977 539 542
48. M.J. Taylor, C. Lafarge Frayssinet, M.I. Luster, and C. Frayssinet Increased endotoxin sensitivity following T-2 toxin treatment is associated with increased absorption of endotoxin Toxicol. Appl. Pharmacol. 109 1991 51 59
49. J.T. Thigpen, C. Vaughn, and W.J. Stuckey Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: a Southwest Oncology Group Study Cancer Treat. Rep. 65 1981 881 882
50. P.A. Van Leeuwen, R.W. Hong, J.D. Rounds, M.L. Rodrick, and D. Wilmore Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin Surgery 110 1991 169 174
51. P.A. Van Leeuwen, M.A. Boermeester, A.P. Houdijk, C.C. Ferwerda, M.A. Cuesta, S. Meyer, and R.I. Wesdorp Clinical significance of translocation Gut 35 1994 S28 S34
52. S.P. Wilkinson, V. Arroyo, B.G. Gazzard, H. Moodie, and R. Williams Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure Lancet 1 1974 521 524
53. G.H. Yang, S. Li, and J.J. Pestka Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin deoxynivalenol Toxicol. Appl. Pharmacol. 162 2000 207 217
54. H.Y. Yap, W.K. Murphy, A. DiStefano, G.R. Blumenschein, and G.P. Bodey Phase II study of anguidine in advanced breast cancer Cancer Treat. Rep. 63 1979 789 791
55. M. Zapor, and J.T. Fishbain Aerosolized biologic toxins as agents of warfare and terrorism Respir. Care Clin. N. Am. 10 2004 111 122
56. X. Zhang, Y. Kluger, Y. Nakayama, R. Poddar, C. Whitney, A. DeTora, S.M. Weissman, and P.E. Newburger Gene expression in mature neutrophils: early responses to inflammatory stimuli J. Leukocyte Biol. 75 2004 358 372
57. H.R. Zhou, J.R. Harkema, D. Yan, and J.J. Pestka Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin deoxynivalenol J. Toxicol. Environ. Health 57 1999 115 136
58. H.R. Zhou, J.R. Harkema, J.A. Hotchkiss, D. Yan, R.A. Roth, and J.J. Pestka Lipopolysaccharide and the trichothecene vomitoxin deoxynivalenol synergistically induce apoptosis in murine lymphoid organs Toxicol. Sci. 53 2000 253 263
59. H.R. Zhou, Z. Islam, and J.J. Pestka Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin Toxicol. Sci. 72 2003 130 142
60. H.R. Zhou, A.S. Lau, and J.J. Pestka Role of double-stranded RNA-activated protein kinase R PKR in deoxynivalenol-induced ribotoxic stress response Toxicol. Sci. 74 2003 335 344